Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.
One in 10 clinics in SA — across 22 health districts in six provinces — could start to hand out a twice-a-year anti-HIV jab ...
Pritelivir demonstrated numerically improved efficacy relative to foscarnet, and a more favourable safety and tolerability ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 22, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the “Company”), announced that its clinical lead drug NV-387 has shown ...
The first ever injectable drug that can prevent HIV has been approved for use in England and Wales.Authors Rosalie Hayes Research Assistant, Centre ...
HPV myths are everywhere, and they’re keeping people misinformed. Misinformation keeps our women and girls unprotected and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results